Vimarsana
Biggest News Aggregation in the World

Two Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Two Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Two Clinical Today - Breaking & Trending Today

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3% - Vimarsana News

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and...

Novel Tool Aims to Simplify Crohn's Disease Assessment - Vimarsana News

Novel Tool Aims to Simplify Crohn's Disease Assessment

A simplified method of scoring Crohn's disease activity and severity can accurately and reliably assess patients, suggests a retrospective analysis.

FDA Approves First Long-Acting Injectable for HIV - Vimarsana News

FDA Approves First Long-Acting Injectable for HIV

“Despite there being many great choices of once-daily pill combinations to treat HIV now, there are many patients who will prefer this option of a once-monthly injection,” says David Hirschwerk, MD, a physician who specializes in infectious disease at Northwell Health in Manhasset, New York. ViiV Healthcare says it will begin shipping Cabenuva to wholesalers and specialty distributors in the United States this month. Injectable Seen as an Important Advance in HIV Treatment William Schaffner, MD, an infectious-disease specialist and a professor of preventive medicine and health policy at t...